Abstract:Objective\r\nIt is well known that the suppression of gastric acidity is one of the most essential factors in promoting healing and preventing relapse of peptic ulcers. Little is known, however, about how to inhibit gastric acid secretion effectively in children with peptic ulcers. The present study aimed at understanding the optimal acid suppression by examining the relationship between ulcer healing and the suppression of gastric acid in children.\r\n\r\n\r\nMethods\r\nPatients with peptic ulcers diagnosed by endoscopy were randomized to receive either oral ranitidine (group A) or oral omeprazole (group B) for 4-6 weeks (mean 5 weeks) . Intragastric 24-hour pH monitoring was performed before treatment, and repeated three times: on day 1, weeks 1 and 5 post-dosing. Endoscopy was repeated on week 5 to evaluate the healing condition of ulcers.\r\n\r\n\r\nResults\r\nTwenty-seven patients followed up by endoscopy and pH monitoring were eligible for final analysis. The ulcers in 16 patients of group A and in all (11 cases) of group B were healed. No significant differences in the gastric mean pH, median pH and percentage of time with gastric pH \u003e 3 between the two groups were observed before treatment. Gastric pH increased significantly after treatment in both groups. These parameters in group A decreased significantly during weeks 1 and 5 as compared to those on day 1 post-dosing; the duration of drug action was also shortened significantly. The gastric mean pH and mean median pH in group B were significantly higher during weeks 1 and 5than on day 1 of post-dosing, the duration of drug action was also prolonged significantly. According to the result of endoscopic re-examination, the authors subdivided group A into unhealed (group C) and healed (group D) groups. The gastric acid suppressive effect in group C attenuated significantly by the end of the 5-week treatment and the differences of gastric mean pH and median pH, percentage of time with pH \u003e 3 between week 5 and pre-treatment level were not significant. While these parameters in group D were still significantly higher during week 5than those obtained before treatment. The gastric mean pH and median pH, percentage of time with pH \u003e 3 and the duration of drug action during week 5 were significantly higher in group D than in group C. The mean shortest duration of drug action in group B was 10 h, while it was 5 h in group D.\r\n\r\n\r\nConclusions\r\nThe onset of tolerance to ranitidine during the therapy might have affected healing of ulcers in the subjects. The optimal acid suppression for healing ulcere in children could be regarded as maintaining the gastric pH \u003e 3 for 5-10 hours a day of post-dosing during 4-6 weeks of anti-secretory treatment.\r\n\r\n\r\nKey words: \r\nPeptic ulcer; Hydrogen-ion concentration; Ranitidine; Omeprazole; Drug tolerance

[Ranitidine and cimetidine in the prevention of stress: ulcer hemorrhage a prospective comparative multicenter study]

Optimal suppression of gastric acid and ulcer healing in children with peptic ulcer

Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study.

Short term treatment of gastric ulcer: a comparison of sucralfate and cimetidine.

Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis

A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU

Prevention of upper gastrointestinal bleeding in critically ill Chinese patients: a randomized, double-blind study evaluating esomeprazole and cimetidine

703 Evaluation of a Stress Ulcer Prophylaxis Protocol in an Burn Intensive Care Unit

The Prevention of Upper Gastrointestinal Bleeding in Seriously Ill Chinese Patients: A Randomised, Double-Blind Study Evaluating Esomeprazole Vs Cimetidine

Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials

Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.

Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.

Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease

[The differentiated treatment of patients with duodenal peptic ulcer]

A randomized controlled study of roxatidine in the prevention of stress related mucosal disease

Pharmacological interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units: a network meta-analysis

A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol

EFFICACY OF INTRAVENOUS ADMINISTRATION OF OMEPRAZOLEIN THE TREATMENT OF UPPER GASTROINTESTINAL HEMORRHAGE CAUSED BY PEPTIC ULCER AND ACUTE GASTRIC MUCOSAL LESION

Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial

Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis

PROTON PUMP INHIBITORS FOR STRESS ULCER BLEEDING PROPHYLAXIS IN CRITICALLY ILL PATIENTS: A COST ANALYSIS STUDY